Technology | April 15, 2013

Elekta Receives FDA 510(k) Clearance for Versa HD Radiation Therapy System

Linear accelerator provides single system versatility to deliver treatments for more patients and cancer types

April 15, 2013 — Elekta recently received 510(k) clearance from the U.S. Food and Drug Administration (FDA), allowing the company to begin shipping and installation of all components of the Versa HD system within the United States.

Featuring high-precision beam shaping and tumor targeting and capable of delivering radiation doses three times faster than previous Elekta linear accelerators, Versa HD sets a higher benchmark for cancer treatment.

Fully integrated with the Agility 160-leaf multileaf collimator (MLC), Versa HD provides high-definition, high-speed beam shaping over a versatile 40 cm by 40 cm field. This unique combination of fast MLC leaf speed with the new High Dose Rate mode empowers clinicians to fully exploit high dose rate delivery and take advanced therapies such as volumetric modulated arc therapy (VMAT), stereotactic radiosurgery (SRS) and stereotactic radiotherapy (SRT) to new levels – without compromising treatment times.

Versa HD also features:

  • Industry-leading safety innovations
  • Customizable, disease-specific configurations
  • Modern patient-friendly ergonomics
  • Fewer delays and downtime with real-time remote system monitoring
  • Low environmental impact, low energy consumption design

 

For more information: www.versahd.com, www.elekta.com

 

 

 

Related Content

Elekta Expands Mosaiq Oncology Information System With PalabraApps
News | Oncology Information Management Systems (OIMS) | April 20, 2018
April 20, 2018 — Elekta announced that it is making a strategic investment in PalabraApps LLC to advance the developm
This image, taken with Canon's Aquilion One, shows a lung with metastases from bowel cancer.

This image, taken with Canon’s Aquilion One, shows a lung with metastases from bowel cancer. Image courtesy of Canon.

Feature | Lung Cancer | April 18, 2018 | Jeff Zagoudis
In recent years, low-dose computed tomography (CT) screening has emerged as a proven, effective method to detect lung
Varian Launches Velocity 4.0 Cancer Imaging Software
Technology | Treatment Planning | April 16, 2018
April 16, 2018 — Varian announced a new version of its Velocity cancer imaging software that includes Rapidsphere, a
First Patient Treated in Online Adaptive Radiotherapy Trial With CyberKnife System
News | Stereotactic Body Radiation Therapy (SBRT) | April 06, 2018
Accuray Inc. and Erasmus MC announced the first patient has been successfully treated using an online-adaptive (OA)...
First Patient Treated on Mevion's S250i Proton Therapy System
News | Proton Therapy | April 05, 2018
Mevion Medical Systems announced the treatment of the first patient in the world on the Mevion S250i Proton Therapy...
ASTRO Updates Guidelines for Palliative Lung Radiation Therapy
News | Radiation Therapy | April 05, 2018
The American Society for Radiation Oncology (ASTRO) issued an update to its clinical guideline for the use of...
Combination Radiotherapy Beneficial in Treating Prostate Cancer
News | Prostate Cancer | March 27, 2018
March 27, 2018 — While there are many treatment options for men with...
Loyola Study Finds Medical Students Receive Little Formal Instruction in Radiation Oncology
News | Radiation Therapy | March 26, 2018
Medical school students receive little formal instruction in radiation oncology, a Loyola study has found.
Overlay Init